Marco Demaria

Marco Demaria has demonstrated that combining conventional chemotherapy with senolytic drugs to clear therapy-induced senescent cells improves cancer treatment outcomes in preclinical models. His one-two punch strategy of inducing senescence with chemotherapy then eliminating senescent cells with senolytics has entered clinical trial evaluation. He maps the temporal dynamics of the SASP to identify optimal windows for senolytic intervention after cancer treatment.